I'm not a patent lawyer but cannot see how "discovery" of Zantrene as a potent FTO inhibitor for oncology is patentable when someone else holds the patent for Zantrene. Particularly when the drug is in clinic for oncology. That would seem to undermine patent rights.
Perhaps this may actually be a stumbling block for CoHinvolving attorneys and increasing the canine affection!
I'm not a patent lawyer but cannot see how "discovery" of...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.030(2.11%) |
Mkt cap ! $247.1M | |||
| Open | High | Low | Value | Volume |
| $1.43 | $1.45 | $1.40 | $163.8K | 115.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 31396 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |